The Association for International Cancer Research uses cookies to ensure we give you the best experience we can. Details can be found in our Cookies Statement. If you continue without changing your settings we assume that you are happy to receive all cookies on the AICR website.

Partnership Success

MRC Technology and AICR Partnership Success for Cancer Research

MRC Technology, a technology transfer charity and company, has reported successful results from the first year of its agreement with the Association for International Cancer Research (AICR). The partnership enables AICR to take advantage of MRC Technology’s IP management, technology transfer, and drug discovery expertise, to help maximise the health benefits and revenue derived from AICR-funded research.

Over the year, MRC Technology’s experts reviewed and monitored 25 priority projects from AICR’s overall portfolio, advising on development and commercialisation as appropriate.

For three of these projects, MRC Technology negotiated revenue share agreements on behalf of AICR with the universities holding the grants. Each of these agreements reflects the value of the support given by AICR towards the success and commercialisation of the research.

Mike Johnson, MRC Technology’s Director of Corporate Partnerships commented: “The success of this relationship is based on the ability of MRC Technology to add value to AICR’s mission, ensuring that research funded by the organisation creates potential new health benefits wherever possible. We look forward to continuing our work with AICR, and to building similar partnerships with other charities and universities.”

Dr Helen Rippon, Head of Science at AICR commented, “We very much value our partnership with MRC Technology, and recognise their expertise in managing and commercialising IP. We are a small team at AICR, and only through our partnership with MRC Technology can we ensure that opportunities are not missed for AICR-funded research to be steered towards patient benefit.  We have found their open, honest and regular communication and flexibility to be of great benefit through the past year. We look forward to continuing the relationship, and further realising returns on AICR-funded research for people affected by cancer”.

"Without the generous support of AICR I would not have been able to continue my research in this particular project, which has proven to be very exciting and has potential benefits that will make a difference to patients."

Louise_Purton highlight

Associate Professor Louise Purton, St Vincent’s Institute of Medical Research, Fitzroy, Melbourne

 

Content managed by CC Technology